Hoenle (HNL.DE) Osake Kurssi
Hoenle Kurssi
Viimeisten 19 vuoden aikana Hoenlen liikevaihto kasvoi 7,5 % vuodessa ja ylsi 93,68 M EUR:een. Osakekohtainen tulos on kasvanut 4,6 % vuodessa viimeisten 13 vuoden aikana. Hoenlen nettomarginaali −3,4 % on pääosin vakaa verrattuna −4,2 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 2,72 %. Hoenlen 12 kuukauden konsensustavoitehinta on 19,38 EUR, noin yli kurssia 164,0 %. 6 analyytikosta 5 suosittaa ostoa — kokonaiskonsensus on Osta.
Hoenle osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Hoenle liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Hoenle -osakkeesta
The business model of Dr Hoenle AG revolves around providing innovative UV technology solutions. As a leading manufacturer of UV systems, the company offers a wide range of products and services. Dr Hoenle AG specializes in developing and producing UV lamps, LED modules, and systems for various industries like automotive, printing, and electronics. With a focus on sustainability and energy efficiency, they deliver high-quality and reliable solutions for curing, bonding, and disinfection applications. Dr Hoenle AG also offers customer-specific solutions along with comprehensive technical support, ensuring their clients' needs are met effectively.
Dr Hoenle AG is primarily active in the fields of adhesives, coatings, and surface technology.
Dr Hoenle AG faces competition from various companies in the market. Some of its main competitors include UV technology providers such as IST METZ GmbH, Heraeus Noblelight GmbH, and Phoseon Technology. These competitors also specialize in manufacturing UV curing systems, UV lamps, and UV LED products. Furthermore, Dr Hoenle AG also contends with other companies involved in industrial adhesives, coatings, and printing industries. Being a leader in UV technology and offering innovative solutions, Dr Hoenle AG strives to maintain its competitive advantage and cater to the diverse needs of its customers.
Dr Hoenle AG is a German technology company specializing in UV technology and industrial adhesives. Founded in 1972 by Dr. Hans Hoenle, the company has an extensive history in providing innovative solutions for various industries. Dr Hoenle AG has established itself as a leader in the field of UV curing technology, offering products such as UV lamps, LED curing systems, and UV adhesives. With a commitment to research and development, the company has continuously improved its products, expanding its global presence and serving customers worldwide. Dr Hoenle AG's dedication to technological advancement and customer satisfaction has made it a trusted brand in the industry.
Dr Hoenle AG, a leading company in its industry, has achieved several significant milestones. The company's commitment to innovation and quality has allowed it to establish a strong presence in the market. Dr Hoenle AG has successfully expanded its product portfolio, offering advanced solutions tailored to various sectors. Furthermore, the company has secured numerous patents, demonstrating its dedication to research and development. Dr Hoenle AG's consistent growth and profitability have been instrumental in establishing its reputation as a reliable and successful player in the industry. As a result of these achievements, the company continues to attract investors and maintain its position as a market leader.
Dr Hoenle AG is primarily present in Germany, where its headquarters are located. Additionally, the company operates globally and has a significant presence in various countries and regions worldwide. With its advanced technologies and high-quality products, Dr Hoenle AG serves customers across Europe, especially in countries like Austria, Switzerland, and France. The company also has a significant presence in North America, catering to customers in the United States and Canada. Overall, Dr Hoenle AG has established itself as a prominent player in the global market, offering innovative solutions and meeting the needs of customers in multiple countries and regions.
Dr Hoenle AG represents values and a corporate philosophy centered on innovation, quality, and sustainability. As a leading company in the field of industrial UV technology, Dr Hoenle AG consistently strives to deliver cutting-edge solutions that meet the highest standards. The company is committed to creating sustainable products and processes, ensuring responsible resource management and minimizing its ecological footprint. With a focus on customer satisfaction, Dr Hoenle AG aims to provide reliable and efficient solutions that contribute to the success and growth of its clients. By continuously investing in research and development, Dr Hoenle AG remains at the forefront of technological advancements, delivering value to its stakeholders and maintaining a strong market presence.
Analyytikot asettavat tällä hetkellä Hoenle-osakkeelle keskimääräisen tavoitehinnan 18,36 EUR (mediaani: 19,38 EUR), mikä merkitsee +150,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 6 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Hoenle-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Hoenle-yhtiöltä 93,60 M EUR liikevaihtoa ja −0,20 EUR osakekohtaista tulosta.
Hoenle-osake (HNL.DE) on listattuna 8 pörssissä, muun muassa: London (0O27.L), SIX (Zürich) (HNL.SW), XETRA (HNL.DE), Frankfurt (HNL.F), München (HNL.MU), Düsseldorf (HNL.DU), Hamburg (HNL.HM).
Dr Hoenle AG is an internationally leading provider of UV technology for industrial applications. The company was founded in 1972 and is headquartered in Gräfelfing near Munich. With around 600 employees and a turnover of almost 100 million euros, the company is a significant player in its field. The business model of Dr Hoenle AG is based on the development, production, and sale of UV technology for a variety of applications. The company offers a wide range of products, divided into three divisions: UV technology for surface disinfection, industrial applications, and 3D printing. The first division includes products for surface disinfection, which are mainly used in medical facilities and the food industry. For example, this includes UV-C devices for air disinfection and surface sterilization. These devices are in high demand during the COVID-19 pandemic, as they effectively act against viruses and bacteria. The second division is the industrial application of UV technology. Here, Dr Hoenle offers a variety of products that can be used in different industries. This includes UV dryers for the printing industry, UV adhesives for automotive construction, and UV coatings for surfaces. The third division is 3D printing, for which Dr Hoenle has developed special UV-LED systems. These enable fast and precise curing of resins used in additive manufacturing. The applications range from prototype production to the production of series components. The business model of Dr Hoenle AG is based on a strong research and development department as well as close cooperation with customers from various industries. The company focuses on continuous innovation and aims to improve the efficiency and sustainability of industrial processes. In order to successfully implement the business model, the company relies on an international orientation. Dr Hoenle is represented in over 60 countries worldwide and operates its own sales and service companies in Europe, Asia, and the USA. In summary, Dr Hoenle AG is an innovative company specializing in UV technology for a variety of applications. The wide product range includes products for surface disinfection, industrial applications, and 3D printing. The business model is based on strong research and development, international orientation, and close cooperation with customers from various industries.
odotettu liikevaihto Hoenle on 93,60 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Hoenle on −1,21 M EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Hoenle:n hinta-voitto-suhde (P/E) on tällä hetkellä −36,71. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Hoenle-osakkeen arvostusta.
Hoenle:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,48. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Hoenle-osakkeen arvostuskennuslukuna.
Hoenle:n Eulpool-laatuscore on 0/10.
Hoenle:n ISIN on DE0005157101. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Hoenle:n WKN on 515710. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Hoenle:n ticker on HNL.DE. Tämä pörssinoteeraus käytetään Hoenle-osakkeiden kauppaan pörssissä.
Hoenle osake
Kaikki tunnusluvut ja syvällinen analyysi Hoenle:sta
Meidän osakeanalyysimme Hoenle-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Hoenle:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: